Sytse Piersma

Medicine & Life Sciences

1. Natural Killer Cells 100%
2. T-Lymphocytes 75%
3. Uterine Cervical Neoplasms 59%
4. Muromegalovirus 54%
5. Regulatory T-Lymphocytes 51%
6. Neoplasms 32%
7. Immunity 31%
8. Virus Diseases 29%
9. Human papillomavirus 16 26%
10. Vaccination 24%
11. Antiviral Agents 22%
12. Vaccines 22%
13. Antigens 21%
14. NK Cell Lectin-Like Receptor Subfamily C 21%
15. Cerebellar Ataxia 20%
16. Natural Killer Cell Receptors 19%
17. Immune Evasion 19%
18. Lymph Nodes 18%
19. Viruses 18%
20. Cytomegalovirus Infections 17%
21. Cytokines 17%
22. Cowpox virus 16%
23. Tumor-Infiltrating Lymphocytes 15%
24. BTB-POZ Domain 15%
25. Dendritic Cells 14%
26. HLA-DQ Antigens 14%
27. Vaccine Immunogenicity 13%
28. Diphtheria Toxin 13%
29. Cytokine Receptors 13%
30. Ligands 13%
31. Squamous Intraepithelial Lesions 12%
32. Immunotherapy 12%
33. Infections 12%
34. Peru 12%
35. Tetanus Toxoid 12%
36. Papillomaviridae 12%
37. Vero Cells 12%
38. Major Histocompatibility Complex 12%
39. Cancer Vaccines 11%
40. Subunit Vaccines 11%
41. In Vitro Techniques 11%
42. Herpesviridae 11%
43. Intervertebral Disc 11%
44. Serum-Free Culture Media 11%
45. Mutation 11%
46. Haplotypes 10%
47. Bites and Stings 10%
48. Interleukin-10 10%
49. Transcription Factors 10%
50. Phenotype 10%